HIV molecular immunology database
Databases
Sequence DB
Resistance DB
Immunology DB
Vaccine Trials DB
HCV Databases
Search
CTL/CD8+ search
T Helper/CD4+ search
Antibody search
Search Help
Tools
All Immuno Tools
Epilign
PeptGen
Motif Scan
Sequence Locator
ELF
Hepitopes
HLA Freq Anal
Mosaic
Epicover
Posicover
Products
Epitope Maps
Epitope Tables
HLATEM
Tools & Links
Publications
Compendia
Reviews
About the Database
How to Cite this Database
Sequence Alignments
Tutorials
Search CTL/CD8+ T-Cell Epitope Database
HIV Protein
Proteins with
defined epitope
s
Proteins with
undefined epitope
s
- ALL -
p17
p17-p24
p24
p24-p2p7p1p6
p2p7p1p6
Gag_Pol_TF
Gag_Pol_TF-Protease
Protease
Protease-RT
RT
RT-Integrase
Integrase
Vif
Vpr
Tat
Rev
Vpu
gp160
Nef
- ALL -
Gag
Gag/Pol
Pol
Vif
Vpr
Tat
Rev
Vpu
Env
Nef
HIV-1
Epitope
Subtype
- ALL -
A
AG
B
C
CRF01_AE
CRF02_AG
D
F
G
HIV-2
M
multiple
U
Immunogen
- ALL -
computer prediction
HIV-1 and GBV-C co-infection
HIV-1 and HCV co-infection
HIV-1 exposed seronegative
HIV-1 infected monocyte-derived
HIV-1 infection
HIV-1 or HIV-2 infection
HIV-2 infection
in vitro stimulation or selection
peptide-HLA interaction
SHIV infection
SIV infection
vaccine
Vaccine details
If Immunogen is Vaccine, additional search details
Vaccine type
- ALL -
adeno-associated virus (AAV)
adenovirus
adenovirus type 5 (Ad5)
alphavirus replicon
B. abortus complex
bacteriophage coat protein
canarypox
canarypox prime with gp120 boost
canarypox prime with gp160 boost
canarypox prime with pseudovirion boost
canarypox prime with recombinant protein boost
coxsackievirus
dihydrolipoyl acetyltransferase E2 protein, of Bacillus stearothermophilus
DNA
DNA prime with Ad5 boost
DNA prime with gp120 boost
DNA prime with gp160 boost
DNA prime with modified vaccinia Ankara (MVA) boost
DNA prime with peptide boost
DNA prime with vaccinia boost
DNA prime with virus-like particle (VLP) boost
DNA with CMV promotor
DNA with CMV promotor with cationic liposome
DNA with protein boost
fowlpoxvirus
fusion protein with anthrax delivery domain
gp120 depleted whole killed virus
hemagglutinating virus of Japan (HVJ)-liposome
hepatitis B surface antigen lipoprotein particles (HsBAg)
herpes simplex virus type-1 (HSV-1) amplicon
HIV-1 peptide in filamentous bacteriophage major coat protein
influenza
influenza prime with vaccinia boost
ISCOM
lipopeptide
liposome
Listeria monocytogenes
measles virus (MV)
Mengo virus
modified vaccinia Ankara (MVA)
non-replicating adenovirus
Other
peptide
peptide in liposome
PLG microparticle
polyepitope
protein
rabies virus
Salmonella
Semliki-Forest Virus with virus-like particle boost
Sendai virus vector system (SeV)
Sindbis
vaccinia
vaccinia prime DNA boost
vaccinia prime with gp120 boost
vaccinia prime with gp160 boost
vaccinia with H1 influenza HA gene cassette
vesicular stomatitis virus (VSV)
virus-like particle (VLP)
Vaccine strain
- ALL -
A clade
A clade 92RW020
A clade consensus
A clade UG5.94UG018
AG recombinant HZ321
B clade
B clade 1007
B clade 1035
B clade 89.6
B clade 89.6P
B clade ARV-2
B clade BH10
B clade BRU
B clade BRVA
B clade consensus
B clade HXB2
B clade HXB3
B clade HXBc2
B clade IIIB
B clade JRFL
B clade JY1
B clade LAI
B clade LR150
B clade MN
B clade NL43
B clade RF
B clade SC
B clade SF2
B clade SIMI
B clade W61D
C clade 96ZM651
C clade 97ZA012
C clade C-96BW04.09
C clade C-96BW15C05
C clade consensus
C clade Du422
CRF02 IC0928
D clade NDK
HIV-2 VLP
M group Consensus
multiple epitope immunogen
natural variants
Other
SIV
ZF1
Vaccine component
- ALL -
anchored gp120
CD4BS
complete genome
Env
Gag
Gag-Pol
gp120
gp120 depleted virus
gp140
gp140ΔCFI
gp140ΔV3
gp160
gp160 deletions
gp160ΔV3
gp41
HIV-1
HPG30
mimotopes
Nef
oligomeric gp140
p17 Gag
p17/p24 Gag
p18 Gag
p24 Gag
Pol
Protease
Rev
RT
Tat
V3
Vif
Vpr
Vpu
Adjuvant
- ALL -
aluminum hydroxide
B. anthracia lethal toxin LF component
B7
beta-glucan lentinan
block copolymer CRL8623
Bupivacaine
cationic block copolymer K2
cationic liposome
CD40
CD80
CD86
Cholera toxin (CT)
Complete Freund's Adjuvant (CFA)
concavalin A-immobilized polystyrene nanospheres
CpG immunostimulatory sequence (ISS)
DDA
DOTAP
E. coli heat labile enterotoxin
E. coli mutant heat labile enterotoxin (LT-R72)
Flex, a dendric cell growth factor
FLt3 ligand (FL)
GM-CSF
HSP70
ICAM
IFNγ
IL-1α
IL-12
IL-15
IL-18
IL-2
IL-2/Ig
IL-4
Immune stimulating complexes (ISCOM)
in vivo electroporation
Incomplete Freund's Adjuvant (IFA)
LFA-3
lipopolysaccharide (LPS)
liposome
LTK63
macrophage activating lipopeptide (MALP)
MF59
MIP-1α
Montanide (ISA 51)
Montanide (ISA 720)
oligomannose
Other
P30
PLG
poly(I:C)
QS21
red blood cells
reovirus alpha 1 protein
Ribi adjuvant (MPL+TDM) (RIBI)
urea
vesicular stomatitis virus glycoprotein (VSV-G)
Species
- ALL -
baboon
chimpanzee
goat
guinea pig
human
humanized mouse
humanized rabbit
macaque
mouse
rabbit
scid-hu mouse
transgenic mouse
MHC/HLA
- ALL -
A*01
A*0101
A*02
A*02.01
A*0201
A*020101
A*0202
A*0205
A*0206
A*0207
A*0214
A*0217
A*03
A*0301
A*0702
A*11
A*1101
A*1103
A*19
A*23
A*2301
A*24
A*2402
A*25
A*2501
A*2601
A*2603
A*29
A*2902
A*30
A*3002
A*3101
A*310102
A*32
A*3201
A*33
A*33 motif
A*3301
A*3303
A*3402
A*4301
A*66
A*6603
A*68
A*6801
A*6802
A*69
A*6901
A*7401
A01
A02
A03
A1
A11
A11.1
A1101
A19
A2
A2 supertype
A2 transgenic
A2.1
A23
A24
A25
A26
A28
A28 supertype
A29
A3
A3 superfamily
A3 supertype
A30
A31
A32
A33
A3?
A66
A68
A68 supertype
A74
B*03
B*04
B*07
B*07-super
B*0702
B*0705
B*08
B*0801
B*13
B*14
B*1401
B*1402
B*1403
B*15
B*1501
B*1503
B*1510
B*1516
B*1517
B*18
B*1801
B*27
B*27 motif
B*2702
B*2703
B*2705
B*35
B*3501
B*3502
B*37
B*3701
B*3801
B*3901
B*3910
B*40
B*4001
B*4002
B*4006
B*42
B*4201
B*4202
B*44
B*4402
B*4403
B*440301
B*440302
B*4415
B*4501
B*51
B*5101
B*5201
B*5301
B*53C1
B*5501
B*57
B*5701
B*5702
B*5703
B*570301
B*58
B*5801
B*5802
B*61
B*62
B*81
B*8101
B07
B08
B12
B13
B14
B15
B1501
B1516
B17
B18
B27
B2705
B35
B37
B38
B39
B40
B4001
B42
B44
B45
B49
B50
B51
B52
B53
B55
B56
B57
B58
B60
B61
B62
B62?
B63
B7
B7 supertype
B70
B71
B7?
B8
B81
C*03
C*07
C*15
C14
CD4+ CTL
Cw*0102
Cw*0202
Cw*03
Cw*0303
Cw*0304
Cw*0401
Cw*040101
Cw*0407
Cw*0501
Cw*0602
Cw*07
Cw*0701
Cw*0702
Cw*0704
Cw*08
Cw*0801
Cw*0802
Cw*0804
Cw*12
Cw*1203
Cw*14
Cw*15
Cw*16
Cw*1701
Cw*18
Cw*1801
Cw03
Cw0304
Cw04
Cw07
Cw08
Cw1
Cw15
Cw2
Cw3
Cw4
Cw5
Cw6
Cw7
Cw8
D
D
d
DPw4.2
DR-1 CD4+ CTL
DR4 CD4+
DRA CD4+
Dd
H-2 Dd
H-2
a
H-2
b
H-2
bxd
H-2
d17
H-2
d
H-2
f
H-2
k
H-2
kd
H-2
p
H-2
q
H-2
u
H-2D
H-2D
b
H-2D
d
H-2D
p
H-2D
q
H-2Dd
H-2K
d
H-2K
k
H-2L
d
H-2a
H-2d
H2-Db
L
d
Mamu-A*01
Mamu-A*11
Mamu-B*03
Mamu-B*04
Mamu-B*17
Patr-B*02
Patr-B*03
Patr-B*14
broad
not B8
polyclonal
Author
 
First  
Last
Country
- ALL -
Australia
Barbados
Botswana
Brazil
Cameroon
Canada
China
Cote D'Ivoire
Democratic Republic of the Congo
Ethiopia
Finland
France
Gambia
Germany
Guinea-Bissau
Haiti
India
Japan
Kenya
Malawi
Netherlands
Nigeria
South Africa
Spain
Switzerland
Tanzania
Thailand
Uganda
United Kingdom
United States
Viet Nam
Zambia
Zimbabwe
Keywords
- ALL -
acute/early infection
adjuvant comparison
antagonism
antibody generation
assay standardization/improvement
binding affinity
characterizing CD8+ T cells
class I down-regulation by Nef
co-receptor
compensatory mutation
computational epitope prediction
cross-presentation by different HLA
dendritic cells
drug resistance
dynamics
early treatment
early-expressed proteins
epitope processing
escape
genital and mucosal immunity
HAART, ART
HIV exposed persistently seronegative (HEPS)
HIV-2
HLA associated polymorphism
immune dysfunction
immune evasion
immunodominance
immunotherapy
kinetics
memory cells
mimics
mother-to-infant transmission
neutralization
optimal epitope
rate of progression
responses in children
review
SIV
structure
subtype comparisons
superinfection
supertype
supervised treatment interruptions (STI)
TCR usage
Th1
Th2
therapeutic vaccine
vaccine antigen design
vaccine-induced epitopes
vaccine-specific epitope characteristics
variant cross-recognition or cross-neutralization
viral fitness and reversion
Questions or comments? Contact us at
immuno@lanl.gov